Department of Pathology & Immunology, Washington University School of Medicine in St. Louis, St. Louis, MO
Department of Pathology & Immunology, Washington University School of Medicine in St. Louis, St. Louis, MO.
Diabetes. 2018 Sep;67(9):1830-1835. doi: 10.2337/db18-0331. Epub 2018 Jul 3.
The role of interferons, either pathogenic or protective, during autoimmune diabetes remains controversial. Herein, we examine the progression of diabetes in NOD mice lacking the type I (IFNAR) or type II (IFNGR) interferon receptor and, for the first time, in mice deficient in both receptors (double knockout [DKO]). All mice were bred, maintained, and monitored in a single specific pathogen-free facility with high female and low male diabetes incidence. Our expectation was that removal of interferon signaling would reduce autoimmune destruction. However, examination of diabetes incidence in the IFNAR- and IFNGR-deficient NOD mice showed a reduction in females and an increase in males. In DKO mice, diabetes occurred only in female mice, at decreased incidence and with delayed kinetics. These results show that interferons act as both positive and negative modulators of type 1 diabetes disease risk dependent on sex.
干扰素在自身免疫性糖尿病中的作用,无论是致病还是保护作用,仍然存在争议。在此,我们研究了缺乏 I 型(IFNAR)或 II 型(IFNGR)干扰素受体的 NOD 小鼠以及首次缺乏两种受体(双重敲除 [DKO])的小鼠的糖尿病进展。所有小鼠均在一个具有高雌性和低雄性糖尿病发病率的单一无特定病原体设施中繁殖、维持和监测。我们预计去除干扰素信号会减少自身免疫性破坏。然而,检查 IFNAR 和 IFNGR 缺陷的 NOD 小鼠的糖尿病发病率显示雌性减少而雄性增加。在 DKO 小鼠中,糖尿病仅发生在雌性小鼠中,发病率降低,发病时间延迟。这些结果表明,干扰素在依赖于性别的 1 型糖尿病疾病风险中既是正调节剂又是负调节剂。